Innovation Pharmaceuticals Inc (IPIX)

[centillion]

Looks like we may have finally reached the blow-up stage for a "Last Gasp" attempt by competitive and combating forces to help drive away the viability of this company and its promising new class of a therapeutic drug with its amazing antiviral, anti-inflammatory, and anti-bacterial properties. Let's hope it can keep its head above the waterline with an anticipated favorable result forthcoming from the ongoing multinational phase 2 trial that's underway!